Scientist, Structure-Based Modeling
Deep Origin · Washington, Vereinigte Staaten Von Amerika · Remote
10000 Remote- und Homeoffice-Jobs online
Deep Origin · Washington, Vereinigte Staaten Von Amerika · Remote
Yellowstone Life Insurance Agency, LLC · Washington, Vereinigte Staaten Von Amerika · Remote
Kestra Financial Independent Advisor · Washington, Vereinigte Staaten Von Amerika · On-site
Kia Veterans Technician Apprenticeship Program (VTAP) · Washington, Vereinigte Staaten Von Amerika · On-site
US Federal Solutions · Washington, Vereinigte Staaten Von Amerika · Hybrid
Gritter Francona · Washington, Vereinigte Staaten Von Amerika · Remote
Noble · Washington, Vereinigte Staaten Von Amerika · Remote
CATHEXIS · Washington, Vereinigte Staaten Von Amerika · On-site
Deep Origin · Washington, Vereinigte Staaten Von Amerika · Remote
Led by Michael Antonov, a co-founder of Oculus, and well-funded by Formic Ventures, Deep Origin is poised to reinvent the way scientists work and life science innovations come to life. We see a future largely free of diseases, with a 150-year lifespan being the norm. To get there, we are building an operating system for science, enabling scientists to be more productive and to bring tomorrow's ideas to life quickly and at a reasonable cost.
Deep Origin is seeking a Scientist with strong expertise in small-molecule docking and benchmarking, molecular dynamics (MD) simulations, and free energy perturbation (FEP), machine learning, to support a transformative ARPA-H initiative. You'll lead the design of robust simulation workflows and analyze protein-ligand structures across a large target panel to support predictive modeling for therapeutic discovery.
Applicants must be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
Why Join Deep Origin?
Deep Origin builds modern infrastructure for computational science at the interface of biology, chemistry, and AI. As part of our ARPA-H program, you’ll shape the future of structure-based modeling for therapeutics.